News and Information

News2018-05-04T03:12:28+00:00

Bonti Announces Dosing of the First Patient in the SHINE-1 Phase 2 Clinical Study Evaluating EB-001 for Scar Reduction

Bonti, a privately-held, clinical-stage biotechnology company, today announced the initiation of the SHINE (Scar Healing Improvement with Neurotoxin E) clinical program, aimed at scar reduction using its novel neurotoxin. The first clinical study, SHINE-1, is a randomized, placebo-controlled, double-blind, parallel arm trial to evaluate the safety and efficacy of EB-001 injections in patients undergoing Mohs micrographic surgery on the forehead. [...]

February 8th, 2018|Categories: Press Releases|

Bonti Announces Close of $15.5 Million Series C Funding and Appointment of David Ramsay as Chief Financial Officer

Latest Financing to Enable Continued Clinical Development of Lead Product EB-001 to Treat Musculoskeletal Pain Bonti, a privately-held, clinical-stage biotechnology company, today announced it successfully closed a $15.5 million Series C financing, bringing the cumulative investment in the Company to over $36 million. Capital from the round will be used to continue developing EB-001, a unique botulinum neurotoxin, for its [...]

January 23rd, 2018|Categories: Press Releases|

Bonti to Present at Two Prestigious Healthcare Conferences

Fauad Hasan, CEO and Co-founder, to Spotlight the Company in San Francisco Bonti, a privately-held, clinical-stage biotechnology company, today announced that Fauad Hasan, CEO and co-founder, will present at the following in San Francisco the same week as the 36th Annual J.P. Morgan Healthcare Conference: The Neuroscience Innovation Forum on Sunday, January 7th at 1:50 PM (PT) The 5th Annual [...]

January 5th, 2018|Categories: Press Releases|

Bonti to Present at Piper Jaffray 29th Annual Healthcare Conference

Fauad Hasan, Co-founder and CEO, to Provide Bonti Highlights on November 29th in New York City Bonti, a privately-held, clinical-stage biotechnology company, today announced that Fauad Hasan, co-founder and CEO, is scheduled to present at the Piper Jaffray 29th Annual Healthcare Conference. The conference is taking place November 28th and 29th at the Lotte New York Palace Hotel in New [...]

November 27th, 2017|Categories: Press Releases|